media – Page 546 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

China hands out landmark nod with lightning speed

GSK’s Cervarix and Merck’s previous version of Gardasil took about 10 years to reach the Chinese market. (Merck)
- Source: fiercepharma
- 942
- May 2, 2018
CFDA Gardasil GSK New Approvals
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) for Treatment of Advanced Cervical Cancer

First Filing Acceptance for an Anti-PD-1 Therapy in Cervical Cancer
- Source: investors.merck
- 643
- May 2, 2018
cervical cancer FDA keytruda Merck
Gilead inks $90m deal with Verily to create “molecular map” of inflammatory disease

Gilead Sciences (NSDQ:GILD) is reportedly slated to pay Alphabet’s Verily Life Sciences $90 million over three years to analyze cells from patients with rheumatoid arthritis, inflammatory bowel disease and lupus-related diseases.
- Source: drugdeliverybusiness
- 644
- May 2, 2018
Gilead Market Views rheumatoid arthritis
7 Side Effects Of Hormonal Birth Control Nobody Told You About

To be clear, this doesn't mean you are likely to experience these side effects after going on birth control. But if you do notice any of them after you start, there could be a connection there, and it's worth talking to your doctor if you don't like the effects you're experiencing or notice anything out of the ordinary. Here are a few possible side effects of hormonal birth control that you may not have been told about.
- Source: drugdu
- 448
- April 30, 2018
Hormonal Birth Control side effects
Researchers’ wearable measures force athletes put on tendons

Researchers from the University of Wisconsin-Madison have detailed a wearable device that can better measure muscle-tendon tension during certain activities, such as walking or running.
- Source: MobiHealthNews
- 2,295
- April 30, 2018
digital health medical device Researches
Multiple sclerosis drug could reduce painful side effects of common cancer treatment

Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published April 27 in the Journal of Experimental Medicine, suggests that a drug already approved to treat multiple sclerosis could mitigate this effect, allowing myeloma patients to successfully complete their treatment and relieving the pain of myeloma survivors.
- Source: medicalxpress.
- 473
- April 28, 2018
multiple myeloma Researches
GSK reports Q1 sales decline

GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs. Profit after tax fell 38 percent to £759 million, while earnings per share dropped to 11.2p from 21.4p a year ago.
- Source: pharmatimes
- 503
- April 28, 2018
Company Insights GSK
CAR-T therapy could be available to NHS patients this year

NHS England chief executive Simon Stevens has indicated that chimeric antigen receptor T-cell therapy (CAR-T) could be available on the NHS this year, offering eligible patients a ‘ground-breaking’ approach to treating cancer.
- Source: pharmatimes
- 5,109
- April 28, 2018
cancer NHS T cell therapy
Specialty Vaccines for Overlooked Infectious Diseases–Challenges and Opportunities

Developing specialty vaccines for emerging and overlooked infectious diseases is a challenging and rewarding enterprise with specific opportunities and problems. Large companies have not historically prioritized this area and instead have focused on the development and commercialization of routine vaccines and vaccines for diseases with more significant global markets.
- Source: fiercepharma
- 489
- April 28, 2018
Researches vaccines
mHealth Program Uses Smartphones to Monitor Medication Adherence

Video directly observed therapy (VDOT), an mHealth platform in which patients use an app to record themselves taking medications, can improve adherence and reduce costs, according to a new study.
- Source: mHealth Intelligence
- 923
- April 28, 2018
mHealth Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.